JHIU
REGN icon

Janus Henderson Investors US’s Regeneron Pharmaceuticals REGN Stock Holding History

Janus Henderson Investors US’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$510M Buy
1,317,162
+486,119
+58% +$180M 0.42% 56
2016
Q4 		$305M Buy
831,043
+16,185
+2% +$6.15M 0.26% 105
2016
Q3 		$327M Sell
814,858
-118,542
-13% -$47.6M 0.28% 88
2016
Q2 		$326M Sell
933,400
-655,230
-41% -$252M 0.28% 83
2016
Q1 		$573M Sell
1,588,630
-350,715
-18% -$145M 0.5% 38
2015
Q4 		$1.05B Sell
1,939,345
-210,692
-10% -$114M 0.9% 16
2015
Q3 		$1B Buy
2,150,037
+160,589
+8% +$86.2M 0.9% 17
2015
Q2 		$1.01B Buy
1,989,448
+347,005
+21% +$169M 0.83% 20
2015
Q1 		$742M Buy
1,642,443
+1,420,299
+639% +$602M 0.61% 26
2014
Q4 		$91.1M Buy
222,144
+26,605
+14% +$10.5M 0.08% 323
2014
Q3 		$70.5M Buy
195,539
+26,329
+16% +$8.82M 0.06% 350
2014
Q2 		$47.8M Sell
169,210
-1,726
-1% -$512K 0.04% 424
2014
Q1 		$51.3M Sell
170,936
-35,770
-17% -$11M 0.05% 391
2013
Q4 		$56.9M Sell
206,706
-59,500
-22% -$17.1M 0.05% 374
2013
Q3 		$83.3M Sell
266,206
-112,745
-30% -$29.7M 0.08% 277
2013
Q2 		$85.2M Buy
+378,951
New +$88.2M 0.09% 264

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Polen Capital Management
Polen Capital Management Boca Raton, Florida $14.5B AUM 5.7% 1-Year Est. Return

Janus Henderson Investors US's REGN Position: Q1 2017 in Review

Janus Henderson Investors US increased its Regeneron Pharmaceuticals (REGN) stake by 58% in Q1 2017, buying an estimated $180M and bringing the position to 1,317,162 shares worth $510M. The position accounts for 0.42% of the portfolio, ranked #56.

Janus Henderson Investors US first reported a position in REGN in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.05B in Q4 2015. 579 funds tracked by Wall St. Rank hold REGN as of Q1 2017.

  • Janus Henderson Investors US held 1,317,162 shares of Regeneron Pharmaceuticals worth $510M as of Q1 2017.
  • Janus Henderson Investors US bought 486,119 Regeneron Pharmaceuticals shares in Q1 2017, an estimated $180M.
  • Regeneron Pharmaceuticals made up 0.42% of Janus Henderson Investors US's portfolio in Q1 2017, its #56 holding.
  • Janus Henderson Investors US first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 16 quarters since.
  • Janus Henderson Investors US's Regeneron Pharmaceuticals position peaked at $1.05B in Q4 2015.
  • 579 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2017.

Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.